135 related articles for article (PubMed ID: 8127145)
21. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
22. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation.
Barrena S; Almeida J; Yunta M; López A; Fernández-Mosteirín N; Giralt M; Romero M; Perdiguer L; Delgado M; Orfao A; Lazo PA
Leukemia; 2005 Aug; 19(8):1376-83. PubMed ID: 15931266
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis.
Shah VO; Civin CI; Loken MR
J Immunol; 1988 Mar; 140(6):1861-7. PubMed ID: 2964486
[TBL] [Abstract][Full Text] [Related]
25. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
26. CD45 isoform expression during T cell development in the thymus.
Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
Eur J Immunol; 1992 Jul; 22(7):1843-50. PubMed ID: 1378021
[TBL] [Abstract][Full Text] [Related]
27. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
29. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
30. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
[TBL] [Abstract][Full Text] [Related]
31. No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma.
Duperray C; Bataille R; Boiron JM; Haagen IA; Cantaloube JF; Zhang XG; Boucheix C; Klein B
Cancer Res; 1991 Jun; 51(12):3224-8. PubMed ID: 1904006
[TBL] [Abstract][Full Text] [Related]
32. Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.
Asma GE; van den Bergh RL; Vossen JM
Clin Exp Immunol; 1986 May; 64(2):356-63. PubMed ID: 3742878
[TBL] [Abstract][Full Text] [Related]
33. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
[TBL] [Abstract][Full Text] [Related]
34. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
[TBL] [Abstract][Full Text] [Related]
35. Patterns of membrane CD45 isoform expression by leukaemic blasts and normal mature myeloid cells.
Master PS; Richards SJ; Roberts BE; Scott CS
Int J Hematol; 1992 Jun; 55(3):235-42. PubMed ID: 1386761
[TBL] [Abstract][Full Text] [Related]
36. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
37. The effects of interleukin 7 (IL-7) on human bone marrow in vitro.
Tushinski RJ; McAlister IB; Williams DE; Namen AE
Exp Hematol; 1991 Sep; 19(8):749-54. PubMed ID: 1678354
[TBL] [Abstract][Full Text] [Related]
38. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
40. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]